2026 NPPES data Cardiovascular Disease Physician NPI 1558369611 MD
Verify on CMS →

Harry Odabashian, MD

Cardiovascular Disease Physician in Albany, New York. This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers — including 24,795 in Cardiovascular Disease Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration — see our methodology.

Federal data — no proprietary rating. We show these CMS records as-is — no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
5K
Medicare Part D claims · 452 beneficiaries · Cardiovascular Disease Physician avg: 3K
Generic prescribing
87%
generic claims · 13% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
76.7/100
▼ 6 pts below national avg 83.1 · Above neutral
Industry payments
$20.85
1 payments · CMS Open Payments (Sunshine Act)
Compiled from official public sources by the PlainDoctor editorial team.

What the federal data shows

Harry Odabashian, MD reported a CMS MIPS final score of 76.7/100 — below the 83.1 national average — and filed 4,532 Medicare Part D claims in 2023.

76.7/100
MIPS score · -6 vs avg
5K
Part D claims, 2023
87%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

Harry Odabashian, MD's MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

77 21st percentile higher than 21% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). Below this entry. 70–80: 118,074 scored providers (25%). This entry sits in this band. 80–90: 129,887 scored providers (27%). Above this entry. 90–100: 189,403 scored providers (40%). Above this entry. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Where Harry Odabashian, MD sits

This provider among cardiovascular disease physician peers

Across the 8,753 cardiovascular disease physician providers who report both Medicare Part D prescribing and a MIPS quality score, Harry Odabashian, MD writes more Part D claims than 70% of them and scores higher on MIPS quality than 25% — placing this provider in the high-volume, lower-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.

Part D claim volume vs MIPS quality, by specialty percentile

Lower volume · High qualityHigh volume · High qualityLower volume · Lower qualityHigh volume · Lower quality0255075100023.146.269.392.4Part D claim volume — percentile in specialtyMIPS quality — percentilePart D claim volume — percentile in specialty: 82 · MIPS quality — percentile: 2Part D claim volume — percentile in specialty: 52 · MIPS quality — percentile: 30Part D claim volume — percentile in specialty: 17 · MIPS quality — percentile: 60Part D claim volume — percentile in specialty: 20 · MIPS quality — percentile: 58Part D claim volume — percentile in specialty: 92 · MIPS quality — percentile: 40Part D claim volume — percentile in specialty: 8 · MIPS quality — percentile: 80Part D claim volume — percentile in specialty: 48 · MIPS quality — percentile: 8Part D claim volume — percentile in specialty: 3 · MIPS quality — percentile: 0Part D claim volume — percentile in specialty: 5 · MIPS quality — percentile: 7Part D claim volume — percentile in specialty: 28 · MIPS quality — percentile: 88Part D claim volume — percentile in specialty: 60 · MIPS quality — percentile: 12Part D claim volume — percentile in specialty: 90 · MIPS quality — percentile: 37Part D claim volume — percentile in specialty: 55 · MIPS quality — percentile: 22Part D claim volume — percentile in specialty: 25 · MIPS quality — percentile: 12Part D claim volume — percentile in specialty: 62 · MIPS quality — percentile: 65Part D claim volume — percentile in specialty: 93 · MIPS quality — percentile: 42Part D claim volume — percentile in specialty: 40 · MIPS quality — percentile: 62Part D claim volume — percentile in specialty: 42 · MIPS quality — percentile: 50Part D claim volume — percentile in specialty: 75 · MIPS quality — percentile: 70Part D claim volume — percentile in specialty: 58 · MIPS quality — percentile: 72Part D claim volume — percentile in specialty: 87 · MIPS quality — percentile: 85Part D claim volume — percentile in specialty: 33 · MIPS quality — percentile: 27Part D claim volume — percentile in specialty: 12 · MIPS quality — percentile: 83Part D claim volume — percentile in specialty: 43 · MIPS quality — percentile: 73Part D claim volume — percentile in specialty: 97 · MIPS quality — percentile: 12Part D claim volume — percentile in specialty: 15 · MIPS quality — percentile: 52Part D claim volume — percentile in specialty: 38 · MIPS quality — percentile: 10Part D claim volume — percentile in specialty: 70 · MIPS quality — percentile: 63Part D claim volume — percentile in specialty: 0 · MIPS quality — percentile: 67Part D claim volume — percentile in specialty: 23 · MIPS quality — percentile: 20Part D claim volume — percentile in specialty: 13 · MIPS quality — percentile: 68Part D claim volume — percentile in specialty: 57 · MIPS quality — percentile: 28Part D claim volume — percentile in specialty: 30 · MIPS quality — percentile: 77Part D claim volume — percentile in specialty: 80 · MIPS quality — percentile: 35Part D claim volume — percentile in specialty: 7 · MIPS quality — percentile: 45Part D claim volume — percentile in specialty: 32 · MIPS quality — percentile: 88Part D claim volume — percentile in specialty: 35 · MIPS quality — percentile: 3Part D claim volume — percentile in specialty: 63 · MIPS quality — percentile: 12Part D claim volume — percentile in specialty: 10 · MIPS quality — percentile: 23Part D claim volume — percentile in specialty: 2 · MIPS quality — percentile: 88Part D claim volume — percentile in specialty: 98 · MIPS quality — percentile: 33Part D claim volume — percentile in specialty: 50 · MIPS quality — percentile: 87Part D claim volume — percentile in specialty: 37 · MIPS quality — percentile: 78Part D claim volume — percentile in specialty: 18 · MIPS quality — percentile: 5Part D claim volume — percentile in specialty: 100 · MIPS quality — percentile: 47Part D claim volume — percentile in specialty: 85 · MIPS quality — percentile: 88Part D claim volume — percentile in specialty: 88 · MIPS quality — percentile: 75Part D claim volume — percentile in specialty: 47 · MIPS quality — percentile: 88Part D claim volume — percentile in specialty: 95 · MIPS quality — percentile: 82Part D claim volume — percentile in specialty: 68 · MIPS quality — percentile: 12Part D claim volume — percentile in specialty: 73 · MIPS quality — percentile: 53Part D claim volume — percentile in specialty: 53 · MIPS quality — percentile: 57Part D claim volume — percentile in specialty: 83 · MIPS quality — percentile: 55Part D claim volume — percentile in specialty: 65 · MIPS quality — percentile: 88Part D claim volume — percentile in specialty: 22 · MIPS quality — percentile: 88Part D claim volume — percentile in specialty: 27 · MIPS quality — percentile: 48Part D claim volume — percentile in specialty: 67 · MIPS quality — percentile: 38Part D claim volume — percentile in specialty: 78 · MIPS quality — percentile: 43Part D claim volume — percentile in specialty: 77 · MIPS quality — percentile: 88Part D claim volume — percentile in specialty: 45 · MIPS quality — percentile: 32Harry Odabashian, MD — Part D claim volume — percentile in specialty: 70 · MIPS quality — percentile: 25
Part D claim volume vs MIPS quality, by specialty percentile

Each dot is one cardiovascular disease physician peer from a representative sample of 60; the gold marker is Harry Odabashian, MD. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.

Board certification likely (heuristic — not verified)

Harry Odabashian, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about Harry Odabashian, MD?

Below national average

NPI registry status

Active

Issued 07/12/2005

NPI 1558369611

Primary specialty

Cardiovascular Disease Physician

Mid-sized

24,795 US NPIs in this specialty

Medicare Part D claims

4,532 49% vs specialty avg

2023 prescription claims

Specialty avg: 3,033

MIPS final score

76.7/100 6.4 pts vs avg

Above neutral band

vs 83.1 national avg

Specialty distribution in New York

How Cardiovascular Disease Physician compares to other specialties among New York providers

New York providers

Largest specialties in New York (% of in-state providers)

Student in an Organized Health Care Education/Training Program — 7.8%Student in an Organized Health Care Education/Training Program7.8%Registered Nurse — 5.2%Registered Nurse5.2%Clinical Social Worker — 4.9%Clinical Social Worker4.9%Social Worker — 4.5%Social Worker4.5%Speech-Language Pathologist — 4.5%Speech-Language Pathologist4.5%Licensed Practical Nurse — 4.3%Licensed Practical Nurse4.3%Cardiovascular Disease Physician — 0.4%Cardiovascular Disease Physician0.4%
Largest specialties in New York (% of in-state providers)

Medicare quality performance — MIPS

Harry Odabashian, MD's 2023 MIPS final score plotted against the Cardiovascular Disease Physician national average

Below national average
MIPS Final Score
76.7/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Cardiovascular Disease Physician) — 76.7/100 vs national avg 83.1

0%100%National avg83%76.7%
MIPS final score (Cardiovascular Disease Physician) — 76.7/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

Harry Odabashian, MD appears in the CMS NPPES registry as a Cardiovascular Disease Physician provider holding MD credentials at 1365 WASHINGTON AVENUE, Albany, NY, 12206, with a listed phone of (518) 264-1800. NPI 1558369611 was issued on 07/12/2005. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what Odabashian most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 4,532 prescription claims written by this provider, covering 452 Medicare beneficiaries and totaling roughly $752K in drug spend, split 13% brand-name and 87% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 76.7/100 for the 2023 performance year (Quality 78, Cost 61), compared with the national average of 83.1.

Cardiovascular Disease Physician is a mid-sized specialty nationwide, with 24,795 enrolled providers across 54 states and an average of 3,033 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

1365 WASHINGTON AVENUE
Albany, NY 12206

Provider Details

NPI 1558369611
Specialty Cardiovascular Disease Physician
Credentials MD
Gender Male
NPI Issued 07/12/2005

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

76.7003
Final Score
Avg: 83.1
77.9602
Quality
61.0409
Cost
74
Promoting Interoperability

Reporting: Group practice

Hospital and facility affiliations

Facilities where Harry Odabashian, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

Albany Medical College
Albany, NY

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Harry Odabashian, MD. Source: openpaymentsdata.cms.gov.

Total received

$21

Largest payer

Novartis Pharmaceuticals Corporation

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — New York NYSBPMC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~100K New York medical licensees in 2023 — they are NOT specific to Harry Odabashian, MD. To verify Harry Odabashian, MD's current license status, search the NYSBPMC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

312
Total board actions, New York 2023
Across 302 cases
3.12
Actions per 1,000 licensees
New York statewide rate
probation
Most common action type
89 cases

NYSBPMC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the New York disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Typical

Harry Odabashian, MD — brand share 13.0%
Cardiovascular Disease Physician average

13% brand-name claims vs 87% generic, on 4,532 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

4,532
Total Claims
$752K
Total Drug Cost
452
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
12,583
Total Day Supply
375,930
Brand vs Generic
13% brand / 87% generic
Brand Drug Cost
$629K
Generic Drug Cost
$123K
Antibiotic Claims
32

Patient Demographics

Average Patient Age
77.4 years
Avg HCC Risk Score
1.24
Gender Split
40% female / 60% male
Age Distribution
<65: 11, 65-74: 149, 75-84: 219, 85+: 73

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What Harry Odabashian, MD prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Atorvastatin Calcium
514
Metoprolol Succinate
480
Ezetimibe
368
Amlodipine Besylate
348
Eliquis
Apixaban
308
Rosuvastatin Calcium
209
Nifedipine Er
Nifedipine
200
Lisinopril
162
Furosemide
143
Simvastatin
139

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Cardiovascular Disease Physician Overview

How Harry Odabashian, MD fits within the Cardiovascular Disease Physician landscape nationally.

24,795
Cardiovascular Disease Physician Providers in US
54
States with Cardiovascular Disease Physician
3,033
Avg Claims per Provider

Harry Odabashian, MD's 4,532 claims are above the specialty average of 3,033.

Nearby Cardiovascular Disease Physician Providers in New York

Other clinicians with the same primary specialty enrolled in New York, drawn from the same CMS NPPES roster as Odabashian.

Compare Cardiovascular Disease Physician nationally: see state-by-state distribution →

Before you book an appointment

Use this federal record as your verification checklist, not as a recommendation.

  • Confirm the NPI record is current in the official CMS registry — providers update their own NPPES details, and moves can lag. Verify this NPI
  • Check the active license and any disciplinary history with the New York medical board — federal registration is not a license check. Credential verification guide
  • Weigh a second option: compare this provider with a nearby Cardiovascular Disease Physician peer on Medicare volume and prescribing patterns. Compare providers

Medicare Part D and MIPS figures describe practice patterns in federal programs only — they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.

Frequently Asked Questions

What is Harry Odabashian, MD's specialty?
Harry Odabashian, MD specializes in Cardiovascular Disease Physician and practices in Albany, New York. Credentials: MD.
How much does Harry Odabashian, MD prescribe under Medicare Part D?
In 2023, Harry Odabashian, MD wrote 4,532 Medicare Part D claims totaling $752K in drug costs for 452 beneficiaries.
What is Harry Odabashian, MD's Medicare quality score?
Harry Odabashian, MD has a CMS MIPS Final Score of 76.7/100 (Quality: 78, Cost: 61). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Harry Odabashian, MD located?
Harry Odabashian, MD is located at 1365 WASHINGTON AVENUE, Albany, NY, 12206. Phone: (518) 264-1800.
What is Harry Odabashian, MD's NPI number?
Harry Odabashian, MD's National Provider Identifier (NPI) is 1558369611, issued on 07/12/2005.
Does Harry Odabashian, MD prescribe more brand-name or generic drugs?
Harry Odabashian, MD's prescribing is 13% brand-name and 87% generic drugs by claim count, with $629K in brand drug costs.
How many Cardiovascular Disease Physician providers are there in the US?
There are 24,795 Cardiovascular Disease Physician providers across 54 states in the US. The average Cardiovascular Disease Physician provider writes 3,033 Medicare Part D claims per year.
What drugs does Harry Odabashian, MD prescribe most often?
Based on 2023 Medicare Part D data, Harry Odabashian, MD's most frequently prescribed drugs include Atorvastatin Calcium, Metoprolol Succinate, Ezetimibe. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Harry Odabashian, MD accept Medicare?
Harry Odabashian, MD appears in CMS Medicare data with 4,532 Part D claims and 452 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Harry Odabashian, MD's credentials?
Harry Odabashian, MD's NPI is 1558369611 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology

Compiled from official public sources by the PlainDoctor editorial team.